Biologics may protect psoriasis patients against severe COVID-19November 2, 2020COVID-19 UpdatesPsoriasisPsoriatic Arthritis
Hand eczema: Pan-JAK inhibitor delgocitinib shows dose-dependent response in phase 2b trialNovember 2, 2020Psoriasis
Data on potential risks of COVID-19 in psoriasis patients limited, but reassuringOctober 23, 2020PsoriasisCOVID-19 UpdatesPsoriatic Arthritis
Non-Whites remain sorely underrepresented in phase 3 psoriasis trialsOctober 20, 2020PsoriasisPsoriatic Arthritis
Study highlights differences between White and Latino patients with psoriasisOctober 6, 2020PsoriasisPsoriatic Arthritis
Shingrix effective in older adults with preexisting immune-mediated disordersOctober 5, 2020Psoriatic ArthritisPsoriasis
Study results suggest ustekinumab may trigger acute CV events early in treatmentSeptember 18, 2020PsoriasisPsoriatic Arthritis
Biologics for psoriasis may also reduce coronary plaqueSeptember 17, 2020PsoriasisPsoriatic Arthritis
COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexateSeptember 16, 2020COVID-19 UpdatesPsoriasisPsoriatic Arthritis
Psoriasis, PsA, and pregnancy: Tailoring treatment with increasing dataSeptember 2, 2020PsoriasisPsoriatic Arthritis
TNF inhibitors linked to inflammatory CNS eventsAugust 25, 2020Psoriatic ArthritisPsoriasisRare Diseases
